The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study.
 
Yiwen Chen
No Relationships to Disclose
 
Xinjun Liang
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Hui Wang
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Yueyin Pan
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Qian Chu
No Relationships to Disclose
 
Guang-Hai Dai
No Relationships to Disclose
 
Liang Kang
No Relationships to Disclose
 
Huiwen Ma
No Relationships to Disclose
 
Jianzhen Shan
No Relationships to Disclose
 
Weijia Fang
No Relationships to Disclose
 
Yu-Long Zheng
No Relationships to Disclose
 
Nong Xu
Research Funding - MSD (Inst)
 
Weiqin Jiang
No Relationships to Disclose
 
Cong Wei
Employment - Innovent Biologics
 
Li Zhao
Employment - Innovent Biologics
 
Tingbo Liang
No Relationships to Disclose